156
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Treatment of follicular lymphoma: current status

&
Pages 7-17 | Received 16 Jun 2008, Accepted 29 Jun 2008, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Frank Herting, Thomas Friess, Sabine Bader, Gunter Muth, Gabriele Hölzlwimmer, Natascha Rieder, Pablo Umana & Christian Klein. (2014) Enhanced anti-tumor activity of the glycoengineered type II CD20 antibody obinutuzumab (GA101) in combination with chemotherapy in xenograft models of human lymphoma. Leukemia & Lymphoma 55:9, pages 2151-5160.
Read now
M.J. Levitt, M. Gharibo, R. Strair, D. Schaar, A. Rubin & J.R. Bertino. (2009) Accelerated R-COP: A Pilot Study for the Treatment of Advanced Low Grade Lymphomas that Has a High Complete Response Rate. Journal of Chemotherapy 21:4, pages 434-438.
Read now

Articles from other publishers (10)

Fatou Samba Diago Ndiaye, Seynabou Fall, Atoumane Faye, Nafissatou Diagne, Awa Cheikh Ndaw, Boundia Djiba & Abdoulaye Pouye. (2015) PROGNOSTIC FACTORS OF NON-HODGKIN LYMPHOMA: RETROSPECTIVE STUDY IN UNIT BLOOD SERVICE OF THE INTERNAL MEDICINE DANTEC IN DAKAR (SENEGAL). Open Journal of Hematology 6, pages 1.
Crossref
Gilad Itchaki, Anat Gafter-Gvili, Meir Lahav, Liat Vidal, Pia Raanani, Ofer Shpilberg & Mical Paul. (2013) Anthracycline-containing regimens for treatment of follicular lymphoma in adults. Cochrane Database of Systematic Reviews.
Crossref
Bridget Charbonneau, Matthew J. Maurer, Zachary S. Fredericksen, Clive S. Zent, Brian K. Link, Anne J. Novak, Stephen M. Ansell, George J. Weiner, Alice H. Wang, Thomas E. Witzig, Ahmet Dogan, Susan L. Slager, Thomas M. Habermann & James R. Cerhan. (2012) Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma. American Journal of Hematology 87:9, pages 880-885.
Crossref
Ingerid Weum Abrahamsen, Synneva Kjellevoll, Margrethe Greve‐Isdahl, Nadia Mensali, Sébastien Wälchli, Shraddha Kumari, Beate Fossum Loland, Torstein Egeland, Arne Kolstad & Johanna Olweus. (2011) T cells raised against allogeneic HLA‐A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells. International Journal of Cancer 130:8, pages 1821-1832.
Crossref
Gayatri Vaidyanathan, Nuttapong Ngamphaiboon & Francisco J. Hernandez-Ilizaliturri. (2011) Clinical spectrum and prognosis of follicular lymphoma with blastoid transformation: case series and a review of the literature. Annals of Hematology 90:8, pages 955-962.
Crossref
Riten Kumar, Paul J. Galardy, Ahmet Dogan, Vilmarie Rodriguez & Shakila P. Khan. (2011) Rituximab in combination with multiagent chemotherapy for Pediatric follicular lymphoma. Pediatric Blood & Cancer 57:2, pages 317-320.
Crossref
Mark S. Walker, Edward J. Stepanski, Carolina Reyes, Sacha Satram-Hoang, Arthur C. Houts & Lee S. Schwartzberg. (2011) Symptom burden and quality of life in patients with follicular lymphoma undergoing maintenance treatment with rituximab compared with observation. Therapeutic Advances in Hematology 2:3, pages 129-139.
Crossref
Gilad Itchaki, Anat Gafter-Gvili, Meir Lahav, Liat Vidal, Pia Raanani, Ofer Shpilberg & Mical Paul. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
WEI ZHANG, LI JIAO, DAO-BIN ZHOU & TI SHEN. (2010) Rituximab purging and maintenance therapy combined with autologous stem cell transplantation in patients with diffuse large B-cell lymphoma. Oncology Letters 1:4, pages 733-738.
Crossref
Ekkehard MössnerPeter BrünkerSamuel MoserUrsula PüntenerCarla SchmidtSylvia HerterRoger GrauChristian GerdesAdam NoporaErwin van PuijenbroekClaudia FerraraPeter SondermannChristiane JägerPamela StreinGeorg FertigThomas FriessChristine SchüllSabine BauerJoseph Dal PortoChristopher Del NagroKarim DabbaghMartin J. S. Dyer, Sibrand Poppema, Christian KleinPablo Umaña. (2010) Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity. Blood 115:22, pages 4393-4402.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.